Product Program year 2024 Source: CMS Open Payments

Instylla Delivery Kit

Device Liquid Embolics for Interventional Radiology

PDI 00812013030000

Open in the dashboard

General payments

$304,025

250 payments

Research payments

$3,028,613

340 payments

Through program year 2024, $304,025 in general payments and $3,028,613 in research payments were reported against Instylla Delivery Kit (Liquid Embolics for Interventional Radiology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2024 General $139,693 118
2024 Research $1,386,642 148
2023 General $79,513 72
2023 Research $981,923 133
2022 General $43,194 20
2022 Research $467,576 45
2021 General $41,625 40
2021 Research $192,473 14

Breakdown

Who paid General payments · program years 2021–2024
  1. Instylla Inc. $304,025 250 payments
Top recipients General payments · program year 2024
  1. Salomao Faintuch Diagnostic Ultrasound · Boston, MA $25,142 18% · 6 payments
  2. David Tahour Vascular & Interventional Radiology · Long Beach, CA $22,804 16% · 12 payments
  3. Kei Yamada Vascular & Interventional Radiology · Atlanta, GA $22,667 16% · 7 payments
  4. Dimitry Rabkin Vascular & Interventional Radiology · Boston, MA $21,317 15% · 6 payments
  5. Suvranu Ganguli Vascular & Interventional Radiology · Boston, MA $11,062 8% · 11 payments

The top 5 of 44 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Vascular & Interventional Radiology Radiology $96,903 75% · 30 practitioners
  2. Diagnostic Ultrasound Radiology $25,142 19% · 1 practitioner
  3. Diagnostic Radiology Radiology $5,534 4% · 7 practitioners
  4. Internal Medicine $1,287 <1% · 2 practitioners
  5. Gastroenterology Internal Medicine $1,125 <1% · 1 practitioner

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Massachusetts $59,941 43% · 6 recipients
  2. California $32,595 23% · 4 recipients
  3. Georgia $22,667 16% · 1 recipient
  4. New York $11,512 8% · 7 recipients
  5. Pennsylvania $3,556 3% · 7 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

250 general · 340 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record